BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38229877)

  • 41. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
    Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
    J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive Complaints Assessment and Neuropsychiatric Disorders After Mild COVID-19 Infection.
    Hammerle MB; Sales DS; Pinheiro PG; Gouvea EG; de Almeida PIFM; de Araujo Davico C; Souza RS; Spedo CT; Nicaretta DH; Alvarenga RMP; Pires KL; Thuler LCS; Vasconcelos CCF
    Arch Clin Neuropsychol; 2023 Feb; 38(2):196-204. PubMed ID: 36464245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors.
    Godoy-González M; Navarra-Ventura G; Gomà G; de Haro C; Espinal C; Fortià C; Ridao N; Miguel Rebanal N; Oliveras-Furriols L; Subirà C; Jodar M; Santos-Pulpón V; Sarlabous L; Fernández R; Ochagavía A; Blanch L; Roca O; López-Aguilar J; Fernández-Gonzalo S
    Crit Care; 2023 May; 27(1):188. PubMed ID: 37189173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review.
    Schou TM; Joca S; Wegener G; Bay-Richter C
    Brain Behav Immun; 2021 Oct; 97():328-348. PubMed ID: 34339806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients.
    Gramaglia C; Gambaro E; Bellan M; Balbo PE; Baricich A; Sainaghi PP; Pirisi M; Baldon G; Battistini S; Binda V; Feggi A; Gai M; Gattoni E; Jona A; Lorenzini L; Marangon D; Martelli M; Prosperini P; Zeppegno P;
    Front Psychiatry; 2021; 12():667385. PubMed ID: 34177656
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes.
    Colizzi M; Comacchio C; De Martino M; Peghin M; Bontempo G; Chiappinotto S; Fonda F; Isola M; Tascini C; Balestrieri M; Palese A
    Ir J Psychol Med; 2024 Feb; ():1-8. PubMed ID: 38351842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.
    Pires L; Reis C; Mesquita Facão AR; Moniri A; Marreiros A; Drummond M; Berger-Estilita J
    JMIR Res Protoc; 2024 Jan; 13():e51820. PubMed ID: 38241071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge.
    He D; Yuan M; Dang W; Bai L; Yang R; Wang J; Ma Y; Liu B; Liu S; Zhang S; Liao X; Zhang W
    Asian J Psychiatr; 2023 Feb; 80():103409. PubMed ID: 36549172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post intensive care syndrome in survivors of COVID-19 who required mechanical ventilation during the third wave of the pandemic: A prospective study.
    Martínez E; Aguilera C; Márquez D; Ziegler G; Plumet J; Tschopp L; Cominotti C; Sturzenegger V; Cimino C; Escobar H; Pereyra C; Hidalgo E; Adanza SP; Morelli DM; Masevicius FD
    Heart Lung; 2023; 62():72-80. PubMed ID: 37348211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis.
    Badenoch JB; Rengasamy ER; Watson C; Jansen K; Chakraborty S; Sundaram RD; Hafeez D; Burchill E; Saini A; Thomas L; Cross B; Hunt CK; Conti I; Ralovska S; Hussain Z; Butler M; Pollak TA; Koychev I; Michael BD; Holling H; Nicholson TR; Rogers JP; Rooney AG
    Brain Commun; 2022; 4(1):fcab297. PubMed ID: 35169700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors.
    Fernández-de-Las-Peñas C; Ryan-Murua P; de-la-Llave-Rincón AI; Gómez-Mayordomo V; Arendt-Nielsen L; Torres-Macho J
    Pain; 2022 Nov; 163(11):2112-2117. PubMed ID: 35121694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No neurochemical evidence of neuronal injury or glial activation in children with Paediatric Acute-onset Neuropsychiatric Syndrome. An explorative pilot study.
    Johnson M; Fernell E; Gillberg C; Fasth A; Dinkler L; Blennow K; Zetterberg H
    World J Biol Psychiatry; 2021 Dec; 22(10):800-804. PubMed ID: 33792486
    [No Abstract]   [Full Text] [Related]  

  • 54. Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection.
    García-Grimshaw M; Sankowski R; Valdés-Ferrer SI
    Curr Opin Neurol; 2022 Jun; 35(3):375-383. PubMed ID: 35283463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.
    Magdy R; Elmazny A; Soliman SH; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassien A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Mohamed J; Hussein M
    J Headache Pain; 2022 Aug; 23(1):101. PubMed ID: 35962348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychiatric sequelae of long COVID-19: Pilot results from the COVID-19 neurological and molecular prospective cohort study in Georgia, USA.
    Chen AK; Wang X; McCluskey LP; Morgan JC; Switzer JA; Mehta R; Tingen M; Su S; Harris RA; Hess DC; Rutkowski EK
    Brain Behav Immun Health; 2022 Oct; 24():100491. PubMed ID: 35873350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-reported outcomes of neurologic and neuropsychiatric symptoms in mild COVID-19: a prospective cohort study.
    Ganesh A; Rosentreter RE; Chen Y; Mehta R; McLeod GA; Wan MW; Krett JD; Mahjoub Y; Lee AS; Schwartz IS; Richer LP; Metz LM; Smith EE; Hill MD;
    CMAJ Open; 2023; 11(4):E696-E705. PubMed ID: 37553227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.
    Shahim P; Tegner Y; Gustafsson B; Gren M; Ärlig J; Olsson M; Lehto N; Engström Å; Höglund K; Portelius E; Zetterberg H; Blennow K
    JAMA Neurol; 2016 Nov; 73(11):1308-1315. PubMed ID: 27654934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.
    Mazza MG; De Lorenzo R; Conte C; Poletti S; Vai B; Bollettini I; Melloni EMT; Furlan R; Ciceri F; Rovere-Querini P; ; Benedetti F
    Brain Behav Immun; 2020 Oct; 89():594-600. PubMed ID: 32738287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
    Ahmed H; Patel K; Greenwood DC; Halpin S; Lewthwaite P; Salawu A; Eyre L; Breen A; O'Connor R; Jones A; Sivan M
    J Rehabil Med; 2020 May; 52(5):jrm00063. PubMed ID: 32449782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.